Sanjay Chanda's Net Worth
$422 Thousand
Who is Sanjay Chanda?
Sanjay Chanda does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, and AN2 Therapeutics, Inc..
SEC CIK
Sanjay Chanda's CIK is 0001571820
Past Insider Trading and Trends
2014 was Sanjay Chanda's most active year for acquiring shares with 6 total transactions. Sanjay Chanda's most active month to acquire stocks was the month of January. 2014 was Sanjay Chanda's most active year for disposing of shares, totalling 8 transactions. Sanjay Chanda's most active month to dispose stocks was the month of February. 2014 saw Sanjay Chanda paying a total of $213,548.45 for 81,073 shares, this is the most they've acquired in one year. In 2015 Sanjay Chanda cashed out on 10,000 shares for a total of $261,264.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Anacor Pharmaceuticals Inc No price found
SVP, Drug Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$26.13 | -$188,735.60 | 29.09K |
Scheduled
|
Mar 4
| ||
Form 4
| +20.86% | 5.02K |
—
|
—
| 29.09K |
Feb 3
| |||
Form 4
| +477.42% | 19.07K |
$6.08 | $115,942.70 | 23.07K |
Dec 19
| |||
Form 4
|
—
|
0
|
$21.13 | -$138,750.00 | 4K |
Scheduled
|
Nov 26
| ||
Form 4
|
—
|
0
|
$15.20 | -$181,144.25 | 4K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +3,741.50% | 27.5K |
—
|
—
| 28.23K |
Mar 15
| |||
Form 4
| +3,741.50% | 27.5K |
—
|
—
| 28.23K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |